The intestinal hypomotility associated with purulent peritonitis is general
ly regarded as a contraindication to enteral nutrition. However, enteral nu
trition may be feasible in suppurative peritonitis if administered with gre
at caution, i.e., assuring the appropriate amount, delivery speed, and osmo
lality of the enteral formulation. Glutamine (Gln) increases muscle protein
synthesis and decreases muscle protein degradation in sepsis, regardless o
f the route of administration. Therefore, administering small amounts of su
pplemental Gin via the enteral route to peritonitis patients may be benefic
ial. Two purulent peritonitis patients received L-Gln through a jejunostomy
tube. The average amount of supplemental Gln was 16 g/d. Systemic inflamma
tory responses, i.e., high temperature and a high serum C-reactive protein
level, persisted throughout the treatment period. Femoral arterial and veno
us blood samples were drawn simultaneously for determination of amino acid
levels before and after 7 d of Gin supplementation. Enterally administered
Gln was well-tolerated by both patients. There was an increase in plasma Gi
n levels after Gin supplementation. Moreover, the release of Gin, alanine,
and phenylalanine from the lower extremities was lower after as compared to
before Gin supplementation. Enteral administration of Gin may be feasible
even in purulent peritonitis. Nutrition 1999;15:29-31. (C) Elsevier Science
Inc. 1999.